- Home
- AES vs SNN Comparison
AES vs SNN Comparison
Compare AES & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AES
- SNN
- Stock Information
- Founded
- AES 1981
- SNN 1856
- Country
- AES United States
- SNN United Kingdom
- Employees
- AES N/A
- SNN N/A
- Industry
- AES Electric Utilities: Central
- SNN Industrial Specialties
- Sector
- AES Utilities
- SNN Health Care
- Exchange
- AES Nasdaq
- SNN Nasdaq
- Market Cap
- AES 9.7B
- SNN 10.8B
- IPO Year
- AES 1991
- SNN 1999
- Fundamental
- Price
- AES $13.04
- SNN $25.32
- Analyst Decision
- AES Buy
- SNN Strong Buy
- Analyst Count
- AES 10
- SNN 1
- Target Price
- AES $22.00
- SNN N/A
- AVG Volume (30 Days)
- AES 16.9M
- SNN 1.1M
- Earning Date
- AES 10-31-2024
- SNN 08-01-2024
- Dividend Yield
- AES 5.31%
- SNN 2.97%
- EPS Growth
- AES N/A
- SNN 39.77
- EPS
- AES 1.44
- SNN 0.35
- Revenue
- AES $12,284,000,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- AES $7.98
- SNN $6.97
- Revenue Next Year
- AES $5.27
- SNN $5.46
- P/E Ratio
- AES $9.07
- SNN $35.30
- Revenue Growth
- AES N/A
- SNN 5.48
- 52 Week Low
- AES $12.97
- SNN $23.65
- 52 Week High
- AES $22.21
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- AES 26.46
- SNN 39.79
- Support Level
- AES $13.27
- SNN $24.93
- Resistance Level
- AES $14.36
- SNN $25.57
- Average True Range (ATR)
- AES 0.55
- SNN 0.37
- MACD
- AES -0.01
- SNN 0.18
- Stochastic Oscillator
- AES 2.55
- SNN 75.38
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio as of year-end 2023 totals over 35 gigawatts, including renewable energy (53%), gas (27%), coal (18%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.